According to the latest research by MarketsandMarkets™, the global Custom Antibody Market is projected to reach $901 million by 2029, growing at a steady pace due to rising demand for personalized medicine, advancements in antibody technology, and increasing investments in biopharmaceutical R&D.

Download an Illustrative overview:

The market's growth is driven by key factors such as:

  • The increasing prevalence of chronic diseases and the need for targeted therapies.
  • Ongoing advancements in technology that enable the production of high-quality, specific antibodies.
  • A surge in R&D funding across biopharmaceutical and biotech companies globally.

Custom antibodies play a critical role in life sciences research and the development of therapeutic products, making them an indispensable part of modern healthcare solutions.

Key Highlights from the Report:

  • Market Size: $901 million by 2029.
  • CAGR: The market is expected to grow at a compound annual growth rate (CAGR) of 9.2% over the forecast period.
  • Key Applications: Diagnostics, therapeutic developments, drug discovery, and personalized medicine.

Regional Insights:

The report highlights that North America holds the largest market share due to significant investments in biotechnology and research. Meanwhile, the Asia-Pacific region is anticipated to experience rapid growth, driven by increased healthcare expenditures, rising R&D activities, and government initiatives.

Request Sample Pages:

Market Leaders:

The report also identifies leading companies in the custom antibody space, including  Thermo Fisher Scientific Inc. (US), GenScript (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc (US), Revvity, Inc. (US), Bio-Techne (US), ROCKLAND IMMUNOCHEMICALS, INC. (US), Laboratory Corporation of America Holdings (US), Inotiv (US), Danaher Corporation (US), Sino Biological, Inc. (China), KANEKA CORPORATION (Japan), OriGene Technologies, Inc. (US), Absolute Biotech (US), Biointron Biologics (China), Cell Signaling Technology, Inc. (US), Curia Global, Inc. (US), Mabtech (Sweden), ACROBiosystems (US), Elabscience Bionovation Inc. (US), Creative Diagnostics (US), CUSABIO TECHNOLOGY LLC (US), BioGenes GmbH (Germany), RayBiotech, Inc. (US), Proteintech Group, Inc (US), IMGENEX INDIA Pvt Ltd. (India), Synbio Technologies (US), ProSci Incorporated (US), Creative Biolabs (US), who are continuously innovating to strengthen their market positions.

Content Source:

https://www.marketsandmarkets.com/PressReleases/custom-antibody.asp

https://www.marketsandmarkets.com/ResearchInsight/custom-antibody-market.asp

https://www.prnewswire.com/news-releases/custom-antibody-market-worth-901-million--marketsandmarkets-302164520.html

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.